Company
Entrada Therapeutics, Inc.
At Entrada, we are driven to transform the lives of patients by establishing a new class of intracellular therapeutics
Also known as Entrada Therapeutics
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Entrada Therapeutics, Inc.
- entradatx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Our mission is to treat devastating diseases with intracellular therapeutics
Funding snapshot
- Total raised
- $151MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $116M2021-03-29
Funding rounds
- Round, 2021
- $116M2021-03-29, SEC form D sold, 26 investors
- Round, 2018
- $34M2018-12-14, SEC form D sold, 10 investors
- Round, 2016
- $600K2016-10-27, SEC form D sold, 2 investors
Loading relationship preview